Compare MTX & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTX | QDEL |
|---|---|---|
| Founded | 1968 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 1992 | N/A |
| Metric | MTX | QDEL |
|---|---|---|
| Price | $72.97 | $28.83 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $81.33 | $40.00 |
| AVG Volume (30 Days) | 200.5K | ★ 1.0M |
| Earning Date | 01-29-2026 | 02-11-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,072,600,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $4.99 | N/A |
| Revenue Next Year | $3.40 | $2.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $49.54 | $19.50 |
| 52 Week High | $76.96 | $44.01 |
| Indicator | MTX | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 72.84 | 49.19 |
| Support Level | $63.65 | $26.50 |
| Resistance Level | $72.56 | $29.97 |
| Average True Range (ATR) | 2.01 | 1.72 |
| MACD | 0.34 | -0.17 |
| Stochastic Oscillator | 96.80 | 44.04 |
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products. The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.